blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2314313

EP2314313 - Vaccine against streptococcus pneumoniae [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.11.2018
Database last updated on 22.08.2024
FormerThe patent has been granted
Status updated on  24.11.2017
FormerGrant of patent is intended
Status updated on  26.07.2017
FormerExamination is in progress
Status updated on  27.12.2016
Most recent event   Tooltip12.06.2020Lapse of the patent in a contracting state
New state(s): SE		published on 15.07.2020  [2020/29]
Applicant(s)For all designated states
GlaxoSmithKline Biologicals S.A.
Rue de l'Institut, 89
1330 Rixensart / BE
[2017/52]
Former [2011/17]For all designated states
GlaxoSmithKline Biologicals S.A.
rue de l'Institut, 89
1330 Rixensart / BE
Inventor(s)01 / Laferriere, Craig Antony Joseph
GlaxoSmithKline Biologicals s.a.
Rue de l'Institut 89
1330 Rixensart / BE
02 / Poolman, Jan
GlaxoSmithKline Biologicals s.a.
Rue de l'Institut 89
1330 Rixensart / BE
 [2017/52]
Former [2011/17]01 / Laferriere, Craig Antony Joseph
GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89
1330 Rixensart / BE
02 / Poolman, Jan
GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89
1330 Rixensart / BE
Representative(s)Johnston, Caroline Louise
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[2017/52]
Former [2011/17]Johnston, Caroline Louise
GlaxoSmithKline Corporate Intellectual Property (CN925.1) 980 Great West Road Brentford
Middlesex TW8 9GS / GB
Application number, filing date10178332.212.09.2001
[2011/17]
Priority number, dateGB2000002274215.09.2000         Original published format: GB 0022742
[2011/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2314313
Date:27.04.2011
Language:EN
[2011/17]
Type: B1 Patent specification 
No.:EP2314313
Date:27.12.2017
Language:EN
[2017/52]
Search report(s)(Supplementary) European search report - dispatched on:EP07.03.2011
ClassificationIPC:A61K39/09, A61P31/04
[2011/17]
CPC:
A61K39/092 (EP,NO,US); A61K39/09 (KR,NO); A61K39/0208 (US);
A61K39/095 (US); A61K39/102 (US); A61K39/13 (US);
A61K39/292 (US); A61K39/39 (NO); A61P11/00 (EP);
A61P27/16 (EP); A61P31/00 (EP); A61P31/04 (EP);
A61P37/00 (EP); A61K2039/55 (EP,US); A61K2039/55572 (EP,US);
A61K2039/6068 (EP,US); Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2017/52]
Former [2011/17]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
Extension statesSI22.09.2010
TitleGerman:Impfstoff gegen Streptococcus Pneumoniae[2011/17]
English:Vaccine against streptococcus pneumoniae[2011/17]
French:Vaccin contre streptococcus pneumoniae[2011/17]
Examination procedure22.09.2010Examination requested  [2011/17]
13.10.2011Amendment by applicant (claims and/or description)
19.12.2011Despatch of a communication from the examining division (Time limit: M08)
28.08.2012Reply to a communication from the examining division
03.06.2013Despatch of a communication from the examining division (Time limit: M09)
09.04.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
18.06.2014Reply to a communication from the examining division
27.05.2015Despatch of a communication from the examining division (Time limit: M06)
04.12.2015Reply to a communication from the examining division
16.12.2016Despatch of a communication from the examining division (Time limit: M04)
18.04.2017Reply to a communication from the examining division
27.07.2017Communication of intention to grant the patent
14.11.2017Fee for grant paid
14.11.2017Fee for publishing/printing paid
14.11.2017Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP01984626.0  / EP1317279
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010984626) is  21.05.2007
Opposition(s)28.09.2018No opposition filed within time limit [2018/49]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
18.06.2014Request for further processing filed
18.06.2014Full payment received (date of receipt of payment)
Request granted
23.10.2014Decision despatched
Fees paidRenewal fee
22.09.2010Renewal fee patent year 03
22.09.2010Renewal fee patent year 04
22.09.2010Renewal fee patent year 05
22.09.2010Renewal fee patent year 06
22.09.2010Renewal fee patent year 07
22.09.2010Renewal fee patent year 08
22.09.2010Renewal fee patent year 09
22.09.2010Renewal fee patent year 10
08.09.2011Renewal fee patent year 11
26.09.2012Renewal fee patent year 12
09.09.2013Renewal fee patent year 13
08.09.2014Renewal fee patent year 14
08.09.2015Renewal fee patent year 15
08.09.2016Renewal fee patent year 16
11.09.2017Renewal fee patent year 17
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT27.12.2017
CY27.12.2017
DK27.12.2017
FI27.12.2017
MC27.12.2017
PT27.12.2017
SE27.12.2017
GR28.03.2018
LU12.09.2018
[2020/29]
Former [2020/27]AT27.12.2017
CY27.12.2017
DK27.12.2017
FI27.12.2017
MC27.12.2017
PT27.12.2017
GR28.03.2018
LU12.09.2018
Former [2019/30]AT27.12.2017
CY27.12.2017
DK27.12.2017
FI27.12.2017
MC27.12.2017
GR28.03.2018
LU12.09.2018
Former [2019/24]AT27.12.2017
CY27.12.2017
DK27.12.2017
FI27.12.2017
MC27.12.2017
GR28.03.2018
Former [2018/51]AT27.12.2017
CY27.12.2017
DK27.12.2017
FI27.12.2017
GR28.03.2018
Former [2018/40]AT27.12.2017
CY27.12.2017
FI27.12.2017
GR28.03.2018
Former [2018/37]CY27.12.2017
FI27.12.2017
GR28.03.2018
Former [2018/26]FI27.12.2017
GR28.03.2018
Former [2018/22]FI27.12.2017
Documents cited:Search[XP]WO0056360  (SMITHKLINE BEECHAM BIOLOG [BE], et al) [XP] 1-14 * page 3 - page 33 * * page 39 - page 71; claims 1-23 *;
 [X]  - WESSELS MICHAEL R ET AL, "Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, US, (19980501), vol. 66, no. 5, ISSN 0019-9567, pages 2186 - 2192, XP009113849 [X] 1-14 * page 2186 - page 2191 *
 [X]  - OGUNNIYI A D ET AL, "IMMUNIZATION OF MICE WITH COMBINATIONS OF PNEUMOCOCCAL VIRULENCE PROTEINS ELICITS ENHANCED PROTECTION AGAINST CHALLENGE WITH STREPTOCOCCUS PNEUMONIAE", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, US, (20000501), vol. 68, no. 5, doi:10.1128/IAI.68.5.3028-3033.2000, ISSN 0019-9567, pages 3028 - 3033, XP001064855 [X] 1-14 * page 3028 - page 3032 *

DOI:   http://dx.doi.org/10.1128/IAI.68.5.3028-3033.2000
 [AP]  - OBARO S K, "Confronting the pneumococcus: a target shift or bullet change?", VACCINE, ELSEVIER LTD, GB, (20001208), vol. 19, no. 9-10, doi:10.1016/S0264-410X(00)00262-0, ISSN 0264-410X, pages 1211 - 1217, XP004227929 [AP] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0264-410X(00)00262-0
ExaminationEP0534764
 WO9818930
 EP0916726
    - SOOD R K ET AL, "Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins", EXPERT OPINION ON INVESTIGATIONAL DRUGS, INFORMA HEALTHCARE, (19980301), vol. 7, no. 3, doi:10.1517/13543784.7.3.333, ISSN 1354-3784, pages 333 - 347, XP002373178

DOI:   http://dx.doi.org/10.1517/13543784.7.3.333
by applicantUS4235877
 US4372945
 EP0072513
 US4474757
 US4596556
 EP0281673
 US4790824
 GB2220211
 WO9006951
 US4940460
 US4941880
 US5064413
 EP0497524
 EP0497525
 WO9214488
 WO9303761
 WO9400153
 EP0594610
 US5312335
 WO9412641
 US5334144
 US5339163
 WO9426304
 US5383851
 WO9508348
 WO9517210
 US5466220
 US5480381
 WO9602555
 WO9605859
 US5503627
 US5520639
 US5569189
 WO9633739
 WO9634960
 WO9640928
 WO9701638
 US5599302
 WO9709994
 WO9713537
 WO9713785
 US5649912
 EP0689454
 WO9732980
 WO9737705
 WO9741151
 WO9741731
 WO9748440
 US5704911
 WO9806734
 EP0834568
 EP0837130
 WO9818930
 WO9821337
 WO9820734
 US5766608
 WO9828037
 EP0594610
 US5804193
 WO9839450
 US5843464
 WO9855606
 WO9903884
 WO9915675
 US5893397
 WO9927961
 WO9934850
 WO9951266
 WO9951188
 WO9953940
 US5993412
 WO9964067
 WO0017370
 WO0029434
 WO0037105
 WO0076540
 WO0113977
 EP1092444
    - PELTOLA ET AL., N. ENGL. J. MED., (1984), vol. 310, pages 1561 - 1566
    - ROGHMANN ET AL., J. GERONTOL., (1987), vol. 42, pages 265 - 270
    - VERGHESE; BERK, MEDICINE (BALTIMORE), (1983), vol. 62, pages 271 - 285
    - FEDSON ET AL., ARCH INTERN MED., (1994), vol. 154, pages 2531 - 2535
    - FINE ET AL., ARCH INTERN MED., (1994), vol. 154, pages 2666 - 2677
    - JAMESON; WOLF, CABIOS, (1988), vol. 4, pages 181 - 186
    - RONDA ET AL., EUR J BIOCHEM, (1987), vol. 164, pages 621 - 624
    - BERRY; PATON, INFECT IMMUN, (199612), vol. 64, no. 12, pages 5255 - 62
    - INFECT. IMMUN., (1996), vol. 64, page 3544
    - SANCHEZ-BEATO ET AL., FEMS MICROBIOL LETT, (1998), vol. 164, pages 207 - 14
    - MOSMANN, T.R.; COFFMAN, R.L., "TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties", ANNUAL REVIEW OF IMMUNOLOGY, (1989), vol. 7, doi:doi:10.1146/annurev.iy.07.040189.001045, pages 145 - 173, XP008013278

DOI:   http://dx.doi.org/10.1146/annurev.iy.07.040189.001045
    - THOELEN ET AL., VACCINE, (1998), vol. 16, pages 708 - 14
    - HELMINEN ME ET AL., INFECT. IMMUN., (1993), vol. 61, pages 2003 - 2010
    - CHALOUPKA 1. ET AL., EUR. JOURNAL CLIN. MICROBIOL. INFECT. DIS., (1996), vol. 15, pages 121 - 127
    - SCHMIDT A. C. ET AL., J VIROL, (200105), pages 4594 - 4603
    - JANSON ET AL., INFECT. IMMUN., (1991), vol. 59, pages 119 - 125
    - STEINER ET AL., CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, (1997), vol. 4, page 415
    - COLLINS ET AL., NATURE, (1977), vol. 270, pages 347 - 9
    - WOODNUT; BERRY, ANTIMICROB. AG. CHEMOTHERAP., (1999), vol. 43, page 29
    - BRUYN ET AL., CLIN. INFECT. DIS., (1992), vol. 14, page 251
    - MUSHER ET AL., J. INFECT. DIS., (2000), vol. 182, page 158
 WO1999EP03038
 WO1999EP03257
 WO1999EP03824
 WO1999EP03823
 WO1999EP03822
 GB19990017977
 GB19990018038
 GB19990018208
 GB19990018302
 WO1999EP06781
 WO2000EP01468
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.